Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-24 @ 7:45 PM
NCT ID:
NCT06618703
Eligibility Criteria:
Inclusion Criteria:
* Patient aged 4 years or more (≥4) and less than 18 years (\<18) at inclusion
* Treated with radiotherapy to part or all of the brain for cancer or hematological malignancy before age 16 (≤15)
* Post-radiotherapy time less than or equal to 5 years (≤5)
* In remission of this pathology at the end of oncological treatments, or, with stable residual disease without treatment for 2 years or more (≥2)
* Signature of informed consent from parents or legal guardian
* Patient affiliated to the social security system or beneficiary of such a system
Exclusion Criteria:
* Patients who have relapsed or developed a second cancer with a post-treatment delay of \< 1 year
* Patient in palliative situation
* Brain irradiation with dosimetric data showing sparing of the hypothalamic-pituitary axis (Dmax hypothalamic-pituitary axis \< 15 Gy)
* Patient with a known hypothalamic-pituitary axis endocrine deficit prior to radiotherapy
* Refusal of child or parents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
18 Years
Study:
NCT06618703
Study Brief:
Protocol Section:
NCT06618703